Developed vs. Emerging Markets: Comparing IEFA and SCHE for Global Diversification

For investors seeking to reduce domestic market concentration, the iShares Core MSCI EAFE ETF (IEFA) and the Schwab Emerging Markets Equity ETF (SCHE) provide two distinct pathways to international diversification. While both funds maintain a low expense ratio of 0.07%, they target fundamentally different economic regions and risk appetites. IEFA focuses on developed markets outside the U.S. and Canada, offering a more conservative approach centered on established economies in Europe, Japan, and Australia. In contrast, SCHE targets emerging markets, providing exposure to high-growth regions, particularly in Asia, though it carries higher inherent risks related to currency fluctuations and political instability. IEFA holds over 2,600 stocks, with heavy weightings in financial services (23%), industrials (20%), and healthcare (10%). Key holdings include ASML Holding, AstraZeneca, and HSBC Holdings. Because of its focus on mature companies, IEFA generally offers a higher dividend yield, appealing to income-oriented investors. SCHE manages over 2,200 companies, with a strong tilt toward technology (27%) and financial services (22%). Its portfolio is led by giants such as Taiwan Semiconductor Manufacturing (TSMC), Tencent Holdings, and Alibaba Group Holding. Notably, TSMC's strong performance—up over 140% year-over-year—has contributed to a lower current beta for SCHE relative to the S&P 500 compared to IEFA. Ultimately, the choice between the two depends on the investor's goal: capital appreciation and growth via SCHE, or stability and income via IEFA. Holding both may provide a comprehensive hedge against U.S. market volatility.